Related Experiment Videos
Intravesical heparin and peripheral neuromodulation on interstitial cystitis
Kadir Baykal1, Temuçin Senkul, Bulent Sen
1GATA Haydarpaşa Training Hospital, Department of Urology, Uskudar/Istanbul, Turkey.
Urologia Internationalis
|May 18, 2005
Summary
This study found that combining intravesical heparin and peripheral neuromodulation significantly improved symptoms for interstitial cystitis patients. This treatment offers a promising alternative for those unresponsive to conventional therapies.
Area of Science:
- Urology
- Pain Management
- Gastroenterology
Background:
- Interstitial cystitis (IC) is a chronic condition causing bladder pain and urinary urgency.
- Patients often experience debilitating symptoms impacting quality of life.
- Conventional treatments may not be effective for all individuals.
Purpose of the Study:
- To evaluate the therapeutic efficacy of combining intravesical heparin with peripheral neuromodulation for interstitial cystitis.
- To assess the impact of this combined therapy on pain, bladder capacity, and voiding frequency.
Main Methods:
- A study included 10 patients (8 female, 2 male) diagnosed with interstitial cystitis unresponsive to prior treatments.
- Patients received weekly intravesical heparin (10,000 units) and peripheral neuromodulation.
- Treatment frequency was adjusted over time, with assessments at 2 and 12 months.
Main Results:
- Significant reductions in day and night voiding frequency were observed at 2 and 12 months.
- Wisconsin pain scores showed substantial improvement, decreasing by approximately 62.5% at 2 months and 62.8% at 12 months.
- Maximal cystometric capacity increased by an average of 54.8% at 2 months and 52.5% at 12 months.
Conclusions:
- The combination of intravesical heparin and peripheral neuromodulation is a viable alternative treatment for interstitial cystitis.
- This approach demonstrates significant therapeutic benefits for patients refractory to other therapies.